UBS Call 85 AZN 20.09.2024/ DE000UM5DED8 /
16/08/2024 08:06:06 | Chg.+0.036 | Bid12:13:36 | Ask12:13:36 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.280EUR | +14.75% | 0.300 Bid Size: 5,000 |
0.320 Ask Size: 5,000 |
AstraZeneca PLC | 85.00 USD | 20/09/2024 | Call |
GlobeNewswire
20/06
Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market Gr...
GlobeNewswire
15/05
Fortress Biotech Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
GlobeNewswire
13/05
Artelo Biosciences Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
08/05
Mitigating Muscle Loss Becoming More Vital, Global Cancer Cachexia Market Projected to Reach $3.3 Bi...
GlobeNewswire
01/04
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: AdTheorent ...
GlobeNewswire
25/03
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Agiliti, In...
GlobeNewswire
25/03
Artelo Biosciences Reports Fiscal 2023 Year-End Financial Results and Provides Business Update
GlobeNewswire
19/03
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Fusion Phar...
GlobeNewswire
15/03
American Kidney Fund Announces 2024 Class of Corporate Members Providing Support in the Fight Agains...
GlobeNewswire
29/02
Kidney Month: 31 Day of Action to Equip and Empower People to Fight Kidney Disease
GlobeNewswire
16/01
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ambrx Bioph...